Inventor · disambiguated record
Yusuke Yamazumi
Also filed as: YAMAZUMI YUSUKE
2 granted patents·5 pending applications·1 citations·filing 2017–2024
31Inventor score
Top patents by PatentIndex Score
7 records- 0165US11312956B2Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expressionTAK CIRCULATOR CO LTD·Filed 2017·Granted Apr 26, 2022·1 cites·1 claims
- 0257US2025009827A1Pharmaceutical, food, and cosmetic compositions and productsUNIV TOKYO·Filed 2024·Application pending·0 cites
- 0352US2025375498A1Neurotrimin function inhibitorUNIV TOKYO·Filed 2023·Application pending·0 cites
- 0447US2022333110A1Nucleic acid that inhibits expression of mex3b gene, mex3b gene expression inhibiting agent, method for inhibiting mex3b gene expression, and prophylactic or therapeutic agent for disease caused by mex3b gene expressionUNIV TOKYO·Filed 2020·Application pending·0 cites
- 0543US2023183698A1Prophylactic or therapeutic agent for at least one type of cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, cholangiocarcinoma and liver cancer, prophylactic or therapeutic agent for said cancer which is used in combination drug in combination with said agent, combination drug comprising said agents, and method for screening for prophylactic or therapeutic agent for cancerUNIV TOKYO·Filed 2021·Application pending·0 cites
- 0640US2021163610A1Refractory asthma prophylactic/therapeutic agent screening method, and refractory asthma prophylactic/therapeutic agentUNIV TOKYO·Filed 2019·Application pending·0 cites
- 0733US11279935B2Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5TAK CIRCULATOR CO LTD·Filed 2017·Granted Mar 22, 2022·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →